REVIEW
|
doi:10.20944/preprints202205.0249.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
X-linked hypophosphatemia; fibroblast growth factor 23; osteomalacia; enthesopathy; secondary hyperparathyroidism; tertiary hyperparathyroidism; chronic kidney disease; oral disease; quality of life; burosumab
Online: 19 May 2022 (04:03:47 CEST)